SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited (SMSPHARMA) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
Key metrics
Price as of 2026-09-02
Stock price
₹373.05
Market cap
3,498 Cr
Stock P/E
34.8
P/B
4.38
Dividend yield
0.1%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 167 Cr | 161 Cr | 246 Cr | 164 Cr | 197 Cr | 173 Cr | 248 Cr | 196 Cr | 242 Cr | 210 Cr | 238 Cr | 207 Cr |
| Operating expenses (approx.) | 139 Cr | 132 Cr | 212 Cr | 131 Cr | 165 Cr | 140 Cr | 207 Cr | 157 Cr | 194 Cr | 167 Cr | 198 Cr | 166 Cr |
| EBITDA | 28 Cr | 29 Cr | 34 Cr | 34 Cr | 31 Cr | 33 Cr | 41 Cr | 39 Cr | 48 Cr | 44 Cr | 40 Cr | 41 Cr |
| OPM % | 16.7% | 18.0% | 13.7% | 20.4% | 16.0% | 19.2% | 16.4% | 20.1% | 20.0% | 20.7% | 16.8% | 19.8% |
| Other income | 0.81 Cr | 1 Cr | 2 Cr | 1 Cr | 1 Cr | 2 Cr | 1 Cr | 0.59 Cr | 1 Cr | 4 Cr | 3 Cr | 2 Cr |
| Interest | 6 Cr | 6 Cr | 6 Cr | 5 Cr | 5 Cr | 4 Cr | 5 Cr | 6 Cr | 6 Cr | 6 Cr | 5 Cr | 5 Cr |
| Depreciation | 8 Cr | 8 Cr | 8 Cr | 8 Cr | 9 Cr | 9 Cr | 9 Cr | 10 Cr | 10 Cr | 10 Cr | 10 Cr | 10 Cr |
| Profit before tax | 15 Cr | 16 Cr | 23 Cr | 22 Cr | 20 Cr | 24 Cr | 29 Cr | 26 Cr | 34 Cr | 31 Cr | 39 Cr | 28 Cr |
| Tax % | 21.0% | 26.9% | 24.8% | 24.9% | 28.7% | 22.7% | 29.4% | 21.6% | 26.0% | 25.3% | 15.7% | 25.1% |
| Net profit | 12 Cr | 11 Cr | 17 Cr | 16 Cr | 14 Cr | 18 Cr | 20 Cr | 20 Cr | 25 Cr | 23 Cr | 33 Cr | 21 Cr |
| EPS (₹) | ₹1.39 | ₹1.36 | ₹2.04 | ₹1.95 | ₹1.69 | ₹2.15 | ₹2.40 | ₹2.31 | ₹2.84 | ₹2.59 | ₹3.58 | ₹2.23 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021 | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 465 Cr | 412 Cr | 563 Cr | 520 Cr | 522 Cr | 709 Cr | 783 Cr | 887 Cr | Sign in for TTM |
| Operating expenses (approx.) | 375 Cr | 332 Cr | 442 Cr | 406 Cr | 468 Cr | 593 Cr | 644 Cr | 716 Cr | Sign in for TTM |
| EBITDA | 90 Cr | 80 Cr | 121 Cr | 114 Cr | 55 Cr | 117 Cr | 139 Cr | 171 Cr | Sign in for TTM |
| OPM % | 19.4% | 19.4% | 21.5% | 22.0% | 10.4% | 16.4% | 17.8% | 19.3% | Sign in for TTM |
| Other income | 3 Cr | 5 Cr | 3 Cr | 5 Cr | 5 Cr | 4 Cr | 6 Cr | 8 Cr | Sign in for TTM |
| Interest | 12 Cr | 12 Cr | 11 Cr | 19 Cr | 22 Cr | 23 Cr | 19 Cr | 23 Cr | Sign in for TTM |
| Depreciation | 19 Cr | 22 Cr | 22 Cr | 32 Cr | 32 Cr | 32 Cr | 34 Cr | 40 Cr | Sign in for TTM |
| Profit before tax | 62 Cr | 51 Cr | 93 Cr | 63 Cr | -6 Cr | 67 Cr | 94 Cr | 131 Cr | Sign in for TTM |
| Tax % | 14.3% | 35.6% | 32.5% | 1.0% | -26.2% | 25.3% | 26.5% | 21.9% | Sign in for TTM |
| Net profit | 53 Cr | 33 Cr | 63 Cr | 62 Cr | -7 Cr | 50 Cr | 69 Cr | 102 Cr | Sign in for TTM |
| EPS (₹) | ₹4.90 | ₹3.73 | ₹7.39 | ₹7.35 | ₹-0.83 | ₹5.89 | ₹8.16 | ₹11.15 | Sign in for TTM |
| Dividend payout % | — | — | — | 4.1% | — | 5.1% | 4.9% | 3.5% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021 | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 8 Cr | 8 Cr | 8 Cr | 8 Cr | 8 Cr | 8 Cr | 9 Cr | 9 Cr |
| Reserves | 331 Cr | 340 Cr | 402 Cr | 462 Cr | 452 Cr | 528 Cr | 631 Cr | 776 Cr |
| Borrowings | 130 Cr | 129 Cr | — | 260 Cr | 253 Cr | 280 Cr | 311 Cr | 365 Cr |
| Other liabilities | 107 Cr | 130 Cr | — | 129 Cr | 167 Cr | 218 Cr | 202 Cr | 212 Cr |
| Total liabilities | 577 Cr | 608 Cr | — | 860 Cr | 880 Cr | 1,034 Cr | 1,153 Cr | 1,362 Cr |
| Fixed assets (net) | 280 Cr | 275 Cr | — | 434 Cr | 409 Cr | 434 Cr | 531 Cr | 531 Cr |
| CWIP | 18 Cr | 42 Cr | — | 11 Cr | 33 Cr | 30 Cr | 35 Cr | 122 Cr |
| Investments | 19 Cr | 4 Cr | — | 22 Cr | 11 Cr | 11 Cr | 12 Cr | 26 Cr |
| Inventories | 136 Cr | 129 Cr | — | 251 Cr | 223 Cr | 234 Cr | 285 Cr | 351 Cr |
| Trade receivables | 26 Cr | 49 Cr | — | 49 Cr | 148 Cr | 236 Cr | 203 Cr | 216 Cr |
| Cash & bank | 15 Cr | 10 Cr | — | 47 Cr | 7 Cr | 36 Cr | 41 Cr | 46 Cr |
| Other assets | 82 Cr | 99 Cr | — | 47 Cr | 47 Cr | 53 Cr | 46 Cr | 70 Cr |
| Total assets | 577 Cr | 608 Cr | — | 860 Cr | 880 Cr | 1,034 Cr | 1,153 Cr | 1,362 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021 | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 40 Cr | 22 Cr | 50 Cr | 82 Cr | 59 Cr |
| Cash from investing | — | — | — | -27 Cr | -30 Cr | -52 Cr | -123 Cr | -131 Cr |
| Cash from financing | — | — | — | -7 Cr | -32 Cr | 31 Cr | 47 Cr | 76 Cr |
| Net cash flow | — | — | — | 6 Cr | -39 Cr | 29 Cr | 5 Cr | 4 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 13 Cr | -7 Cr | -2 Cr | -42 Cr | -71 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019 | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021 | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 15.8% | 18.1% | 25.3% | 11.2% | 2.3% | 11.0% | 11.8% | 13.4% |
| ROE % | 15.7% | 0.0% | 15.2% | 13.7% | 0.0% | 0.0% | 10.7% | 13.0% |
| Debtor days | 20 | 43 | — | 34 | 103 | 122 | 95 | 89 |
| Inventory days | 162 | 182 | — | 236 | 271 | 201 | 207 | 248 |
| Days payable | 0 | 0 | — | 68 | 137 | 130 | 83 | 85 |
| Cash conversion cycle | 182 | 225 | — | 201 | 237 | 192 | 218 | 251 |
| Debt / equity | 0.38 | 0.00 | — | 0.55 | 0.55 | 0.52 | 0.49 | 0.46 |
| Current ratio | 1.42 | 1.51 | — | 1.92 | 1.61 | 1.61 | 1.71 | 1.81 |
| Net debt / EBITDA | 1.28 | 0.00 | 0.00 | 0.00 | 4.50 | 2.09 | 1.94 | 1.86 |
Compare with peers
Loading peers…